Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
32.92B | 32.81B | 32.70B | 31.49B | 29.89B | 29.05B | Gross Profit |
2.90B | 2.22B | 2.99B | 2.32B | 2.21B | 2.04B | EBIT |
528.00M | 904.00M | 532.00M | 999.00M | 982.00M | 691.00M | EBITDA |
2.22B | 2.19B | 1.99B | 1.84B | 2.20B | 1.34B | Net Income Common Stockholders |
58.00M | 242.00M | 137.00M | 207.00M | 677.00M | -208.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
739.00M | 3.39B | 2.00B | 1.81B | 1.02B | 1.67B | Total Assets |
12.34B | 24.65B | 25.06B | 26.39B | 27.15B | 25.47B | Total Debt |
2.77B | 6.61B | 6.55B | 7.14B | 7.38B | 6.94B | Net Debt |
2.03B | 3.83B | 4.56B | 5.83B | 6.56B | 5.36B | Total Liabilities |
6.71B | 18.00B | 18.19B | 19.13B | 18.73B | 18.77B | Stockholders Equity |
5.63B | 6.65B | 6.87B | 7.25B | 8.42B | 6.70B |
Cash Flow | Free Cash Flow | ||||
681.00M | 505.00M | 400.00M | 1.66B | 202.00M | 1.50B | Operating Cash Flow |
1.32B | 1.36B | 1.97B | 2.39B | 896.00M | 2.10B | Investing Cash Flow |
-803.00M | -787.00M | -1.01B | -725.00M | -651.00M | -575.00M | Financing Cash Flow |
-992.00M | -1.12B | -282.00M | -960.00M | -1.02B | -1.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $8.07B | 18.47 | 6.29% | 4.49% | 2.28% | 154.64% | |
77 Outperform | $2.26B | 20.56 | 7.80% | 1.61% | 2.00% | 5.89% | |
77 Outperform | $16.36B | 44.39 | 30.81% | ― | 12.90% | 50.20% | |
73 Outperform | $47.15B | 19.42 | 26.59% | 1.74% | -1.94% | 23.94% | |
71 Outperform | $12.28B | 11.91 | 31.26% | 2.27% | 1.46% | -26.54% | |
65 Neutral | $1.55B | 39.88 | 3.27% | ― | 10.13% | -50.29% | |
64 Neutral | $9.28B | 14.55 | 4.62% | 186.42% | 3.98% | 5.64% |